NCT01568723View on ClinicalTrials.gov

Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation

CompletedOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

August 16, 2018

Study Completion Date

August 16, 2018

Conditions
Barrett's Esophagus
Interventions
GENETIC

response to therapy

evaluate specific markers for response to therapy at specific intervals pre and post therapy

Trial Locations (2)

10032

Columbia University, New York

19104-4311

University of Pennsylvania Perelman School of Medicine, Philadelphia

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER